Iparomlimab Plus Tovorilimab Combined With Bevacizumab and Chemotherapy as First-Line Treatment for Advanced Mesothelioma
NCT07514793
·
clinicaltrials.gov ↗
PHASE2
Phase
NOT_YET_RECRUITING
Status
37
Enrollment
OTHER
Sponsor class
Conditions
Mesothelioma
Interventions
DRUG:
Iparomlimab and Tuvoraleimab injection+Bevacizumab+Pemetrexed+Cisplatin
Sponsor
Fudan University